drugset / Trial / NCT02831257
AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas
Phase 2
Completed
18 enrolled
Massachusetts General Hospital
AstraZeneca · collabUnited States Department of Defense · collab
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn if the study drug AZD2014 can shrink growing or symptomatic meningiomas.
Timeline
- Start
- 2016-08-31
- Primary completion
- 2019-05-31
- Completion
- 2020-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vistusertib | Small molecule | — | Oral |